Home › Compare › CBDG vs EPRT

CBDG vs EPRT: Dividend Comparison 2026

CBDG yields 10989.01% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBDG wins by $139745618573216752.00M in total portfolio value
10 years
CBDG
CBDG
● Live price
10989.01%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$139745618573216752.00M
Annual income
$137,288,015,193,820,900,000,000.00
Full CBDG calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — CBDG vs EPRT

📍 CBDG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBDGEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBDG + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CBDG pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBDG
Annual income on $10K today (after 15% tax)
$934,065.93/yr
After 10yr DRIP, annual income (after tax)
$116,694,812,914,747,770,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, CBDG beats the other by $116,694,812,914,747,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBDG + EPRT for your $10,000?

CBDG: 50%EPRT: 50%
100% EPRT50/50100% CBDG
Portfolio after 10yr
$69872809286608376.00M
Annual income
$68,644,007,596,910,450,000,000.00/yr
Blended yield
98.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CBDG
No analyst data
Altman Z
-0.4
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBDG buys
0
EPRT buys
0
No recent congressional trades found for CBDG or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBDGEPRT
Forward yield10989.01% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$139745618573216752.00M ✓$63.4K
Annual income after 10y$137,288,015,193,820,900,000,000.00 ✓$12,840.73
Total dividends collected$139582332248243472.00M ✓$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CBDG vs EPRT ($10,000, DRIP)

YearCBDG PortfolioCBDG Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$1,109,601$1,098,901.10$11,205$505.18+$1.10M → CBDG
2$115,144,457$113,957,183.82$12,672$682.46+$115.13M → CBDG
3$11,175,031,832$11,051,827,262.66$14,490$930.48+$11175.02M → CBDG
4$1,014,391,872,891$1,002,434,588,831.62$16,786$1,282.69+$1014391.86M → CBDG
5$86,126,575,454,415$85,041,176,150,421.60$19,753$1,791.56+$86126575.43M → CBDG
6$6,840,183,785,764,310$6,748,028,350,028,084.00$23,677$2,541.64+$6840183785.74M → CBDG
7$508,187,488,422,178,800$500,868,491,771,411,000.00$29,008$3,672.99+$508187488422.15M → CBDG
8$35,321,082,287,764,525,000$34,777,321,675,152,794,000.00$36,463$5,425.08+$35321082287764.48M → CBDG
9$2,296,825,588,220,420,700,000$2,259,032,030,172,512,500,000.00$47,238$8,221.57+$2296825588220420.50M → CBDG
10$139,745,618,573,216,750,000,000$137,288,015,193,820,900,000,000.00$63,385$12,840.73+$139745618573216752.00M → CBDG

CBDG vs EPRT: Complete Analysis 2026

CBDG — Stock

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

Full CBDG Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this CBDG vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBDG vs SCHDCBDG vs JEPICBDG vs OCBDG vs KOCBDG vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.